<?xml version="1.0" encoding="UTF-8"?>
<p id="par0285">HPLC-DAD quantification of TT revealed the presence of compounds that are pertinent in treating neurological disorders. Aridanin demonstrated anticonvulsive property by modulating nuerotransmitter and opioid receptors [
 <xref rid="bib0170" ref-type="bibr">35</xref>]. Cerebral infarct size in the brain of rats following cerebral ischemia was reduced by treatment with ferulic acid through antioxidative and anti-inflammatory effects [
 <xref rid="bib0310" ref-type="bibr">63</xref>] and naringenin regulated the expression of inflammatory molecules to give neuroprotection in rats after focal ischemia [
 <xref rid="bib0315" ref-type="bibr">64</xref>]. Isoliquiritigenin and scopoletin treatment protected the brain of rats following transient cerebral ischemiic injury through antioxidative, anti-inflammatory, anti-convulsive and mitochondrial modulatory effect [
 <xref rid="bib0320" ref-type="bibr">[65]</xref>, 
 <xref rid="bib0325" ref-type="bibr">[66]</xref>, 
 <xref rid="bib0330" ref-type="bibr">[67]</xref>].
</p>
